Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

This bill requires doctors in New Jersey to offer patients a test for dihydropyrimidine dehydrogenase (DPD) deficiency before starting chemotherapy. DPD deficiency can cause severe reactions when the body cannot properly process certain chemotherapy drugs. Health insurance plans in New Jersey must cover one annual DPD test and related treatment at the same level as other medical conditions. It applies to individual, group, and employer-sponsored health plans, ensuring patients aren't burdened with out-of-pocket costs for this preventive screening. The goal is to prevent harmful drug reactions by identifying at-risk patients before treatment begins.